More

    CStone Announces Inclusion of Cejemly ® (sugemalimab) as a First-Line Combination Therapy for NSCLC in ESMO Guideline



    [
    CStone Announces Inclusion of Cejemly ® (sugemalimab) as a First-Line Combination Therapy for NSCLC in ESMO Guideline
    [og_img]
    https://www.investing.com/news/press-releases/cstone-announces-inclusion-of-cejemly–sugemalimab-as-a-firstline-combination-therapy-for-nsclc-in-esmo-guideline-93CH-3857994


    Investing.com

    Latest articles

    spot_imgspot_img

    Related articles

    Leave a reply

    Please enter your comment!
    Please enter your name here

    spot_imgspot_img